Registry following medical care of people with moderate-to-severe atopic dermatitis in Switzerland
Records how people with moderate-to-severe atopic dermatitis are treated in everyday care.
Key facts
- Who runs it
- Swiss Society of Dermatology and Venereology
- Where
- Basel, Bern, Buochs, Fribourg, Lausanne, Lucerne, Sankt Gallen, Uster, and Zurich, SwitzerlandSee the 9 sites
- Trial code
- Registry title
- Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- 2 Jun 2022
- Expected to end
- 31 Dec 2032
- Type of study
- Observational
- Record updated
- 30 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for people aged 12 or older with moderate to severe atopic dermatitis (a long-lasting inflammatory skin disease) in Switzerland.
- Age
- 12 years or older
- Sex
- All sexes can join.
- Disease stage
- Moderate to severe atopic dermatitis: objective SCORAD above 20, or IGA 3 or higher, or current systemic anti-inflammatory treatment, or such treatment within the past 24 months.
- Earlier treatment
- Not required. Having had systemic anti-inflammatory treatment within the past 24 months is one way to qualify.
- Biomarker or test result
- Atopic dermatitis according to the UK Working Party's Diagnostic Criteria.
Main reasons for not taking part
- People who refuse to sign the informed consent form cannot join.
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age ≥ 12 years
- AD according to the UK Working Party's Diagnostic Criteria (28)
- Moderate to severe AD as defined by
- objective SCORAD > 20 or IGA ≥ 3 (moderate) or
- currently on systemic antiinflammatory therapy for AD or
- previous systemic antiinflammatory therapy for AD within past 24 months
Who cannot take part
- refusal to sign the informed consent form
Where in Switzerland
- Universitätsspital Basel, AllergologieBasel, SwitzerlandContact: Karin Hartmann, Prof. Dr. med.Taking people
- Inselspital, Department of DermatologyBern, SwitzerlandContact: Dagmar Simon, Prof. Dr. med.Taking people
- Dermatology & Skin Care ClinicBuochs, SwitzerlandContact: Ahmad Jalili, PD Dr. Dr. med.Taking people
- HFR Hôpital Cantonal de FribourgFribourg, SwitzerlandContact: Basile Page, Dr. med.Taking people
- Dermatologie CHUVLausanne, SwitzerlandContact: Teofila Caplanusi, Dr. med.Taking people
- Luzerner Kantonsspital, Zentrum für Dermatologie und AllergologieLucerne, SwitzerlandContact: Christoph Brand, Prof. Dr. med.Not yet recruiting
- Kantonsspital St. Gallen - Klinik für Dermatologie, Venerologie und AllergologieSankt Gallen, SwitzerlandContact: Ieva Saulite, Dr. med.Taking people
- PLAZA KlinikenUster, SwitzerlandContact: Tobias Plaza, Dr. med.Taking people
- Institut für Dermatologie und Venerologie Stadtspital Zürich EuropaalleeZurich, SwitzerlandContact: Siegfried Borelli, Dr. med.Taking people
About the trial
What the trial wants to find out
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - Swiss National Clinical Registry TREATswitzerland
- Plain-language title
- Registry following medical care of people with moderate-to-severe atopic dermatitis in SwitzerlandGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 April 2025